Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 92851-92900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04546620
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2Active, not recruiting
453 participants
Started: Oct 19, 2021 · Completed: May 31, 2028
1 condition2 sponsors33 locations
NCT05150405
A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
PHASE1Recruiting
54 participants
Started: Oct 19, 2021 · Completed: Jun 1, 2024
2 conditions1 sponsor1 location
NCT04893226
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
NARecruiting
164 participants
Started: Oct 19, 2021 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT05049655
Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers
N/AEnrolling by invitation
2,000 participants
Started: Oct 19, 2021 · Completed: Oct 31, 2026
1 condition1 sponsor9 locations
NCT05062031
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NAActive, not recruiting
242 participants
Started: Oct 19, 2021 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT04986566
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
NAActive, not recruiting
134 participants
Started: Oct 19, 2021 · Completed: Feb 7, 2026
1 condition3 sponsors1 location
NCT05044546
A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers
NAActive, not recruiting
26 participants
Started: Oct 19, 2021 · Completed: Mar 31, 2026
2 conditions5 sponsors1 location
NCT05003310
ConsideRAte Study - Splenic Stimulation for RA
NARecruiting
28 participants
Started: Oct 19, 2021 · Completed: Apr 30, 2032
1 condition3 sponsors14 locations
NCT04668001
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
NAActive, not recruiting
19 participants
Started: Oct 19, 2021 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT04908423
Xeomin® and Gait Related Mobility After Stroke
PHASE4Recruiting
20 participants
Started: Oct 19, 2021 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT03865160
Low-dose Atropine for Myopia Control in Children
PHASE2/PHASE3Active, not recruiting
302 participants
Started: Oct 19, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor19 locations
NCT05142215
A Placebo-controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention for the Relief of Stable Angina
NARecruiting
50 participants
Started: Oct 19, 2021 · Completed: Oct 1, 2025
2 conditions2 sponsors2 locations
NCT05115214
Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
NARecruiting
50 participants
Started: Oct 19, 2021 · Completed: Oct 15, 2027
1 condition1 sponsor2 locations
NCT04781322
Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers
PHASE1Recruiting
100 participants
Started: Oct 19, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05083481
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
PHASE1/PHASE2Recruiting
366 participants
Started: Oct 19, 2021 · Completed: May 31, 2028
1 condition2 sponsors41 locations
NCT04809376
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
PHASE2/PHASE3Active, not recruiting
602 participants
Started: Oct 19, 2021 · Completed: Jan 6, 2025
1 condition1 sponsor33 locations
NCT05066997
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
PHASE2/PHASE3Active, not recruiting
552 participants
Started: Oct 19, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor52 locations
NCT05238155
Evaluation of the Impact of Reduced Immunosuppression
N/AEnrolling by invitation
100 participants
Started: Oct 19, 2021 · Completed: Oct 19, 2024
1 condition1 sponsor1 location
NCT04664686
Rate or Rhythm Control in CRT: the RHYTHMIC Study
NARecruiting
70 participants
Started: Oct 19, 2021 · Completed: Aug 29, 2026
2 conditions2 sponsors1 location
NCT04847063
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
PHASE1Recruiting
60 participants
Started: Oct 19, 2021 · Completed: Dec 30, 2031
5 conditions1 sponsor1 location
NCT05141058
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
PHASE1Recruiting
24 participants
Started: Oct 19, 2021 · Completed: Dec 15, 2027
1 condition1 sponsor2 locations
NCT05161728
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer
NARecruiting
150 participants
Started: Oct 19, 2021 · Completed: Oct 19, 2025
1 condition1 sponsor4 locations
NCT04460573
Smart Boot Use to Measure Offloading Adherence
PHASE2Recruiting
210 participants
Started: Oct 19, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT05097872
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NARecruiting
65 participants
Started: Oct 19, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2Active, not recruiting
50 participants
Started: Oct 19, 2021 · Completed: Oct 19, 2025
1 condition1 sponsor7 locations
NCT05173350
RETAIN Kentucky Impact Evaluation
NAEnrolling by invitation
3,200 participants
Started: Oct 18, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05023174
Platelet Rich Plasma in Hiatal Hernia Repair
NAEnrolling by invitation
150 participants
Started: Oct 18, 2021 · Completed: Jul 1, 2025
2 conditions1 sponsor2 locations
NCT04198857
Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
NARecruiting
220 participants
Started: Oct 18, 2021 · Completed: Dec 18, 2026
2 conditions5 sponsors1 location
NCT04584320
Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization
N/AActive, not recruiting
40 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06153563
Evaluation of the Elasticity of the Mitral Valve
N/ARecruiting
30 participants
Started: Oct 18, 2021 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05073952
Keratized Mucosa in CG Implant Placement: CTG vs Flapless
NARecruiting
44 participants
Started: Oct 18, 2021 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT05356325
FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
N/ARecruiting
401 participants
Started: Oct 18, 2021 · Completed: Jul 1, 2025
3 conditions2 sponsors1 location
NCT05057182
Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)
PHASE4Active, not recruiting
300 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05044117
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
PHASE3Recruiting
220 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2026
1 condition10 sponsors1 location
NCT06089031
Belgian Registry on Coronary Function Testing
N/ARecruiting
650 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor13 locations
NCT05010993
Establishing Czech Norms of Selected Standardized Tests
N/ARecruiting
540 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05104866
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
PHASE3Active, not recruiting
732 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors167 locations
NCT03873428
Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES
NARecruiting
25 participants
Started: Oct 18, 2021 · Completed: Oct 18, 2025
1 condition1 sponsor2 locations
NCT04795661
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
PHASE2Active, not recruiting
240 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2029
2 conditions1 sponsor17 locations
NCT05124652
An Automatically Adjusting Prosthetic Socket for People With Transtibial Amputation
NARecruiting
100 participants
Started: Oct 18, 2021 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT05331105
HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
PHASE2Recruiting
70 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2028
2 conditions1 sponsor1 location
NCT05081492
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
PHASE1Active, not recruiting
9 participants
Started: Oct 18, 2021 · Completed: Mar 30, 2026
3 conditions3 sponsors1 location
NCT04958239
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
PHASE1Recruiting
160 participants
Started: Oct 18, 2021 · Completed: Nov 19, 2028
1 condition1 sponsor50 locations
NCT04998422
A Study of HG381 Administered to Patients With Advanced Solid Tumors
PHASE1Recruiting
57 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05577000
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
5 participants
Started: Oct 18, 2021 · Completed: Oct 1, 2043
2 conditions4 sponsors1 location
NCT05092542
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
NAActive, not recruiting
1,212 participants
Started: Oct 18, 2021 · Completed: Jul 31, 2026
4 conditions2 sponsors1 location
NCT04961762
Navigator Program for Homeless Adults
NAActive, not recruiting
656 participants
Started: Oct 18, 2021 · Completed: Aug 1, 2025
4 conditions2 sponsors1 location
NCT04673448
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
PHASE1Active, not recruiting
18 participants
Started: Oct 18, 2021 · Completed: Sep 30, 2026
27 conditions2 sponsors1 location
NCT06068335
Innate Immunity in Allergic Asthma
N/ARecruiting
100 participants
Started: Oct 18, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05099809
Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers
N/ARecruiting
500 participants
Started: Oct 18, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location